Impact of shortened dental arch on oral health-related quality of life over a period of 10 years - A randomized controlled trial.

Longitudinal modelling OHRQoL Oral rehabilitation RCT Shortened dental arches

Journal

Journal of dentistry
ISSN: 1879-176X
Titre abrégé: J Dent
Pays: England
ID NLM: 0354422

Informations de publication

Date de publication:
01 2019
Historique:
received: 05 07 2018
revised: 20 09 2018
accepted: 17 10 2018
pubmed: 26 10 2018
medline: 27 11 2019
entrez: 26 10 2018
Statut: ppublish

Résumé

To compare oral health-related quality of life (OHRQoL) in patients with either molar replacement by partial removable dental prostheses (PRDP) or with restored shortened dental arches (SDA) over a period of 10 years. In this multi-center RCT, a consecutive sample of 215 patients with bilateral molar loss in at least one jaw was initially recruited in 14 prosthodontic departments. Of those patients, 150 could be randomly allocated to the treatment groups (SDA: n = 71; PRDP: n = 79), received the allocated treatment, and were available for follow-up assessments. OHRQoL was assessed using the 49-item version of the Oral Health Impact Profile (OHIP) before treatment (baseline) and at follow-ups after treatment (4-8 weeks and 6, 12, 24, 36, 48, 60, 96, and 120 months). To investigate the course of OHRQoL over time, we longitudinally modelled treatment and time effects using mixed-effects models. OHRQoL substantially improved from baseline to first follow-up in both groups indicated by a mean decrease in OHIP scores of 20.0 points (95%-CI: 12.5-27.5). When compared to the SDA group, OHRQoL in the PRDP group was not significantly different (-0.6 OHIP points; 95%-CI: -7.1 to 5.9) during the study period when assuming a constant time effect. OHRQoL remained stable over the 10 years with a statistically insignificant time effect (p = 0.848). For patients requesting prosthodontic treatment for their lost molars, treatments with SDA or PRDP improve clinically relevantly OHRQoL and maintain it over a period of 10 years with no option being superior to the other. Since there was no significant difference between the two treatment options over the observation period of 10 years, and since results have stayed stable over time, patients can be informed that both treatment concepts are equivalent concerning OHRQoL.

Identifiants

pubmed: 30355509
pii: S0300-5712(18)30609-2
doi: 10.1016/j.jdent.2018.10.006
pii:
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

55-62

Informations de copyright

Copyright © 2018 Elsevier Ltd. All rights reserved.

Auteurs

Daniel R Reissmann (DR)

Department of Prosthetic Dentistry, Center for Dental and Oral Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: d.reissmann@uke.de.

Stefan Wolfart (S)

Department of Prosthodontics and Biomaterials, Medical Faculty, RWTH Aachen University, Aachen, Germany.

Mike T John (MT)

Department of Diagnostic and Biological Sciences, School of Dentistry, University of Minnesota, Minneapolis, MN, USA.

Birgit Marré (B)

Department of Prosthetic Dentistry, Technische Universität Dresden, University Hospital Carl Gustav Carus Dental School, Dresden, Germany.

Michael Walter (M)

Department of Prosthetic Dentistry, Technische Universität Dresden, University Hospital Carl Gustav Carus Dental School, Dresden, Germany.

Matthias Kern (M)

Department of Prosthetic Dentistry, Christian-Albrechts University, Kiel, Germany.

Ralf Kohal (R)

Department of Prosthetic Dentistry, Albert-Ludwig University of Freiburg, Freiburg, Germany.

Frank Nothdurft (F)

Department of Prosthetic Dentistry and Dental Materials Sciences, Saarland University, Homburg, Saar, Germany.

Helmut Stark (H)

Department of Prosthodontics, Preclinical Education and Dental Materials Science, University of Bonn, Bonn, Germany.

Oliver Schierz (O)

Department of Prosthodontics and Materials Science, University of Leipzig, Leipzig, Germany.

Bernd Wöstmann (B)

Department of Prosthetic Dentistry, Justus-Liebig University of Giessen, Giessen, Germany.

Wolfgang Hannak (W)

Department of Prosthodontics, Geriatic Dentistry and Craniomandibular Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Torsten Mundt (T)

Department of Prosthodontics, Gerodontology and Biomaterials, Dental School, Ernst-Moritz-Arndt University of Greifswald, Greifswald, Germany.

Peter Pospiech (P)

Department of Prosthodontics, Geriatic Dentistry and Craniomandibular Disorders, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Julian Boldt (J)

Department of Prosthodontics, University of Würzburg, Würzburg, Germany.

Daniel Edelhoff (D)

Department of Prosthetic Dentistry, University Hospital, LMU Munich, Munich, Germany.

Eckhard Busche (E)

Department of Prosthetic Dentistry, Witten-Herdecke University, Witten, Germany.

Florentine Jahn (F)

Department of Prosthetic Dentistry and Dental Material Science, Friedrich-Schiller University of Jena, Jena, Germany.

Ralph G Luthardt (RG)

Department of Prosthetic Dentistry, Center of Dentistry, Ulm University, Ulm, Germany.

Sinsa Hartmann (S)

Department of Prosthetic Dentistry, Johannes- Gutenberg University of Mainz, Mainz, Germany.

Guido Heydecke (G)

Department of Prosthetic Dentistry, Center for Dental and Oral Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH